Haoyue Pang
Overview
Explore the profile of Haoyue Pang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Fang X, Wang D, Li Q, Zhang K, Li Y, et al.
Cryobiology
. 2024 Feb;
115:104864.
PMID: 38387752
The aim of this study was to investigate the therapeutic effect of cryoablation treatment in advanced NSCLC patients who had failed first-line chemotherapy. Eighty-seven patients from ten hospitals in China...
2.
Wang Z, Hu F, Chang R, Yu X, Xu C, Liu Y, et al.
Technol Cancer Res Treat
. 2022 Nov;
21:15330338221133222.
PMID: 36412085
Lung adenocarcinoma (LUAD) is the most common subtype of non-small-cell lung cancer (NSCLC). The aim of our study was to determine prognostic risk factors and establish a novel nomogram for...
3.
Pang H, Hu K, Li F, Duan H, Chen Y, Hu Y, et al.
Bioengineered
. 2022 Apr;
13(4):11258-11268.
PMID: 35481548
Thermal ablation is widely used in the treatment of lung cancer and is beneficial for the overall survival of patients in clinic. However, there is barely a priority in which...
4.
Lin X, Zhou T, Hu S, Yang L, Yang Z, Pang H, et al.
J Thorac Dis
. 2022 Apr;
14(3):654-667.
PMID: 35399245
Background: Numerous studies have revealed that the abnormal expression of pyroptosis-related genes is closely related to the prognosis of lung adenocarcinoma (LUAD); however, a comprehensive analysis has yet to be...
5.
Zhang Z, Wang J, Duan H, Liu D, Zhou X, Lin X, et al.
In Vivo
. 2021 Jun;
35(4):2005-2014.
PMID: 34182475
Background/aim: Xihuang Wan (XHW), a traditional Chinese medicine (TCM), has been used in China for a variety of cancers including lung cancer. The present study evaluated the efficacy of XHW...
6.
Sun M, Chen Q, Li Q, Gao L, Zhou Q, Zhou T, et al.
Medicine (Baltimore)
. 2020 Nov;
99(47):e23294.
PMID: 33217859
Background: Gastroparesis affects the quality of life of many patients, but there is no effective treatment. Now, complementary and alternative medicine originated from China is gradually accepted by the world...
7.
Duan H, Zheng S, Luo C, Fang X, Wang D, Pang H, et al.
BMJ Open
. 2020 Sep;
10(9):e033460.
PMID: 32895259
Introduction: National Comprehensive Cancer Network has recommended cryoablation to replace the resection in the treatment of medically operable non-small cell lung cancer (NSCLC). Cryoablation also has been used for the...
8.
Sun M, Zhou T, Fang X, Wang D, Pang H, Chen Y, et al.
Medicine (Baltimore)
. 2020 Sep;
99(33):e21626.
PMID: 32872022
Background: Chemotherapy is the main therapy for stage IIIB/IV non-small cell lung cancer (NSCLC). However, the 5-year survival rate is 6%. Cancer Green Therapy is a novel therapy in China,...